Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition. - Wikidata - wikimedia - TriplyDB

Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition.

Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition.

http://www.wikidata.org/entity/Q33814824

about

Epoxyeicosatrienoic acids and cardioprotection: the road to translation The role of epoxyeicosatrienoic acids in the cardiovascular system Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor Soluble epoxide hydrolase: gene structure, expression and deletion Development of an HTS assay for EPHX2 phosphatase activity and screening of nontargeted libraries Redox regulation of soluble epoxide hydrolase by 15-deoxy-delta-prostaglandin J2 controls coronary hypoxic vasodilation Epoxides and soluble epoxide hydrolase in cardiovascular physiology Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice Role of soluble epoxide hydrolase phosphatase activity in the metabolism of lysophosphatidic acids.11,12-EET stimulates the association of BK channel α and β(1) subunits in mitochondria to induce pulmonary vasoconstriction.Soluble epoxide hydrolase inhibitor attenuates inflammation and airway hyperresponsiveness in mice.N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase.Pulmonary hypertension after prolonged hypoxic exposure in mice with a congenital deficiency of Cyp2j.Activation of JNK/c-Jun is required for the proliferation, survival, and angiogenesis induced by EET in pulmonary artery endothelial cells.Epoxyeicosatrienoic acids and endothelium-dependent responses.Soluble epoxide hydrolase regulates hematopoietic progenitor cell function via generation of fatty acid diols.EET-dependent potentiation of pulmonary arterial pressure: sex-different regulation of soluble epoxide hydrolase.Roles of the epoxygenase CYP2J2 in the endothelium.Optimization of isolated perfused/ventilated mouse lung to study hypoxic pulmonary vasoconstriction.TRPV4 channel contributes to serotonin-induced pulmonary vasoconstriction and the enhanced vascular reactivity in chronic hypoxic pulmonary hypertension.EETs Elicit Direct Increases in Pulmonary Arterial Pressure in Mice Cyp2c44 gene disruption exacerbated pulmonary hypertension and heart failure in female but not male mice Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke.The cytochrome P450 pathway in angiogenesis and endothelial cell biology.Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases.Cardiotonic Pill Reduces Myocardial Ischemia-Reperfusion Injury via Increasing EET Concentrations in Rats.Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta.EETs promote hypoxic pulmonary vasoconstriction via constrictor prostanoids.Soluble epoxide hydrolase deficiency or inhibition enhances murine hypoxic pulmonary vasoconstriction after lipopolysaccharide challenge.Bacterial Expression and HTS Assessment of Soluble Epoxide Hydrolase Phosphatase.Sexually Dimorphic Regulation of EET Synthesis and Metabolism: Roles of Estrogen

P2860

Q28241262-17E3025E-10AE-4B72-99B1-2B2BB3F9FACA Q28256560-55E02A77-5707-48B5-8BBE-6BFFBA7C2E6C Q28270421-AD4C77C4-EC88-48C1-961E-B7D09B755690 Q28291292-5C572D1A-C695-408C-8726-944C8079D392 Q28393751-CCB2F323-AE6C-445E-A535-4337D84A457D Q28395654-4523ED55-C120-4758-BCE8-8E326CFAAEA8 Q28396313-6C71D48E-6AAA-42C5-87C9-2161A2BB4AFE Q28398028-C66CBE11-4175-42CB-8781-647B59F55B78 Q34183871-4CD46B61-A4A9-4A18-8D21-E40DEF4AA7F3 Q34430758-B629F4E4-9984-4F9D-93CC-293CDA331F61 Q35207683-7DE75FF3-496B-4569-9758-A55BA6F597F0 Q35624665-BB23FB1D-3D79-4EC6-8415-6DE3D5A8BB47 Q35816434-2FC3C8C1-62B0-4C6A-9746-7F3CCFE8D7F4 Q35958442-509EEA7D-70CA-47BE-B103-C07217DC4029 Q36027656-83C561C5-52DD-492B-94C5-560BA9299991 Q36056415-31F00571-F4DA-464B-8E7F-77F1D4BDC8F7 Q36382133-21F2F2A1-7488-4955-B680-3E1A2E9CE22E Q37014713-ED1E976F-9C7D-43B3-B832-F67E9FED764B Q37133827-56FF4D42-7F9D-4D60-97E2-DCC44E7DAEDB Q37234560-D92427F4-AF43-410F-AC04-93FE789CB220 Q37238103-70D3DD75-BBF0-4838-8EA8-1FBAA896C30C Q37248337-0700F297-7B1D-462E-91F8-F3DC8D059647 Q37440238-EB0396CF-9A59-43F6-A42F-D329CD74255D Q37947082-8A45723F-B3A1-4021-9E3C-3B209C0D32A2 Q38184587-EB3F5B58-7FAC-48BC-B039-EA644FCE5511 Q39791243-A4035220-0FFC-4536-9756-C6B5E282BC1C Q41439393-94B33A03-566C-4B21-965E-A13698711E40 Q45931712-0A89E64A-C3EE-4846-B138-D35DBEFBE2C0 Q46368082-1CE1AF48-BBF4-477C-BC1D-AEF919DDAAA7 Q51299486-66063C39-44FE-429F-9BAA-9556670F6C2A Q58699067-28E11E9C-A543-4FE8-9F9A-483A102DEAD4

P2860

Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition.

http://www.wikidata.org/entity/Q33814824

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Hypoxia-induced pulmonary hype ...... olase deletion vs. inhibition.

@ast

Hypoxia-induced pulmonary hype ...... olase deletion vs. inhibition.

@en

type

label

Hypoxia-induced pulmonary hype ...... olase deletion vs. inhibition.

@ast

Hypoxia-induced pulmonary hype ...... olase deletion vs. inhibition.

@en

prefLabel

Hypoxia-induced pulmonary hype ...... olase deletion vs. inhibition.

@ast

Hypoxia-induced pulmonary hype ...... olase deletion vs. inhibition.

@en

P1433

Q33814824-B08FA683-5492-4978-8B1E-0A81680D9B96

P1476

Q33814824-963FDF33-CBD2-41B2-938E-295A857DCFD3

P2093

Q33814824-0155BDD8-582E-498B-BEE3-EBE06542A9E9

Q33814824-5D30BB03-1E8B-4341-B965-6A1086F09796

Q33814824-9CC02213-0FAA-428F-B034-278E97AC9752

Q33814824-B910E1FD-863D-4AAE-BD4D-B24675953444

Q33814824-D947EB0E-982C-4CE6-8E5F-8420034FED72

P2860

Q33814824-04328D6F-6102-4B44-884D-DF34CBE0ED49

Q33814824-16DF22DB-37FD-42EC-8162-B480019FDE6F

Q33814824-1DC97D84-3BBB-482E-8903-A37DC582577C

Q33814824-1F52D550-FBD5-4D95-834D-4E8CA3FAFB9A

Q33814824-27875E9D-F915-4877-A81E-EDBFA8FB2307

Q33814824-3906A3D7-B238-42DB-9D50-7F98AC6F758D

Q33814824-3B03C49B-31B5-4770-AE06-AEBA08715CE3

Q33814824-452BFF3B-3F55-49F9-8883-05628DADA975

Q33814824-4A835B4E-0027-4A83-A106-0BE6EE9B01BC

Q33814824-4F33A60A-CBCC-4450-8923-4B79926DB493

P304

Q33814824-25033ABE-9EFB-4330-AADC-7CECF1449F62

P31

Q33814824-3D207C4F-AF3D-4B35-B295-6999EE1454C9

P356

Q33814824-6D2FC5C7-E310-4F40-B5EC-7A873BDA8312

P433

Q33814824-6FF6F6A8-E3B6-477A-9180-AC39314F1075

P478

Q33814824-6635BE4D-253A-4F4D-8E37-DAD08618AC0D

P50

Q33814824-174D61E9-A80C-495E-9AB8-14AB46318C0A

Q33814824-A9FFCFE5-9FFB-4083-B50F-19B645CACC28

Q33814824-AE2E5112-C69D-431A-B238-5279179F286C

P577

Q33814824-BE5D24E4-FDA8-4EDF-A3A6-C3342165CCBB

P698

Q33814824-73625AFA-88D5-4FA7-9E51-C30EAE53A249

P921

Q33814824-FD587135-FE64-492C-9A7D-C587C6DA64DE

P932

Q33814824-F16DE22A-8DFA-499A-B58A-6D15F241FA9F

P356

P1433

Cardiovascular Research

P1476

Hypoxia-induced pulmonary hype ...... rolase deletion vs. inhibition

@en

P2093

Beate Fisslthaler

http://www.w3.org/2001/XMLSchema#string

Benjamin Keserü

http://www.w3.org/2001/XMLSchema#string

Bruce D Hammock

http://www.w3.org/2001/XMLSchema#string

Eduardo Barbosa-Sicard

http://www.w3.org/2001/XMLSchema#string

Hiromasa Tanaka

http://www.w3.org/2001/XMLSchema#string

P2860

The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase

The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity

Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase

cDNA cloning and expression of a soluble epoxide hydrolase from human liver

Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolase

Basic features of hypoxic pulmonary vasoconstriction in mice

Congenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxia

Soluble epoxide hydrolase gene deletion reduces survival after cardiac arrest and cardiopulmonary resuscitation

Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response

Alteration in plasma testosterone levels in male mice lacking soluble epoxide hydrolase

P304

232-240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CVR/CVP281

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

Ralph T Schermuly

Norbert Weissmann

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19679679

http://www.w3.org/2001/XMLSchema#string

P921

P932

2860707

http://www.w3.org/2001/XMLSchema#string